The latest closing stock price for PMV Pharmaceuticals as of March 07, 2025 is 1.23.
An investor who bought $1,000 worth of PMV Pharmaceuticals stock at the IPO in 2020 would have $-967 today, roughly -1 times their original investment - a -57.45% compound annual growth rate over 4 years.
The all-time high PMV Pharmaceuticals stock closing price was 61.51 on December 31, 2020.
The PMV Pharmaceuticals 52-week high stock price is 2.26, which is 83.7% above the current share price.
The PMV Pharmaceuticals 52-week low stock price is 1.20, which is 2.4% below the current share price.
The average PMV Pharmaceuticals stock price for the last 52 weeks is 1.60.
An investor who bought $1,000 worth of PMV Pharmaceuticals stock at the IPO in 2020 would have $-967 today, roughly -1 times their original investment - a -57.45% compound annual growth rate over 4 years.
The all-time high PMV Pharmaceuticals stock closing price was 61.51 on December 31, 2020.
The PMV Pharmaceuticals 52-week high stock price is 2.26, which is 83.7% above the current share price.
The PMV Pharmaceuticals 52-week low stock price is 1.20, which is 2.4% below the current share price.
The average PMV Pharmaceuticals stock price for the last 52 weeks is 1.60.